Oxytocin

A cyclic nonapeptide neurohormone produced in the hypothalamus and released by the posterior pituitary. Oxytocin is FDA-approved as Pitocin for labor induction, labor augmentation, and management of postpartum hemorrhage. It is one of the most extensively studied peptide hormones in existence and was the first to be sequenced and synthesized (Vincent du Vigneaud, 1953 Nobel Prize).

Beyond its established obstetric indications, intranasal oxytocin has been investigated in over 1,500 clinical trial participants for social cognition, anxiety, autism spectrum disorder, and PTSD, though results have been inconsistent and methodologically debated. In biohacking and integrative medicine communities, compounded intranasal oxytocin is discussed in the context of social bonding, stress reduction, and mood support.

Oxytocin is a well-characterized, FDA-approved nonapeptide with decades of obstetric use. Off-label intranasal application for psychiatric and social-cognitive conditions (autism, social anxiety, PTSD, depression) is an active but methodologically contested research area. A 2020 systematic review flagged low statistical power and limited replication across intranasal studies.

The peptide's extremely short IV half-life limits systemic applications, but nose-to-brain transport provides a practical non-invasive delivery pathway with a favorable short-term safety profile. Community use of compounded intranasal sprays for mood and bonding support is widespread but not supported by robust chronic-use safety data.